Category: Life Sciences
Global Life Sciences
-
Cervical Pillows
... CAGR of 5.4% over the analysis period 2024-2030. Standard Pillows, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More
-
Clinical Data Analytics
... at a CAGR of 34.4% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$32.6 Billion by the end of ... Read More
-
Coconut Milk
... CAGR of 16.1% over the analysis period 2024-2030. Conventional Coconut Milk, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Complex-Oxide Nanomaterials
... CAGR of 11.9% over the analysis period 2024-2030. Lithium Titanate, one of the segments analyzed in the report, is expected to record a 12.3% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More
-
Computational Biology
... CAGR of 18.1% over the analysis period 2024-2030. Contract Services, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$20.1 Billion by the end of the analysis ... Read More
-
Connected Medical Devices
... at a CAGR of 18.8% over the analysis period 2024-2030. Connected Capital Intensive Devices, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$131.5 Billion by the ... Read More
-
Contract Packaging
... CAGR of 8.7% over the analysis period 2024-2030. Food & Beverage End-Use, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$55.4 Billion by the end of ... Read More
-
Dengue Testing
... CAGR of 4.8% over the analysis period 2024-2030. ELISA-Based Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$383.2 Million by the end of the analysis ... Read More
-
Diabetic Food
... CAGR of 4.8% over the analysis period 2024-2030. Dietary Beverages, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$6.2 Billion by the end of the analysis ... Read More
-
DNA and RNA Sample Preparation
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. DNA and RNA Sample Preparation Kits, one of the segments analyzed in the report, is expected to record a 4.5% CAGR ... Read More
-
Drug Screening
... CAGR of 16.7% over the analysis period 2024-2030. Drug Screening Products, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$16.7 Billion by the end of the ... Read More
-
Electronic Health Records (EHR)
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Acute EHR, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$26.3 Billion by the ... Read More
-
Exosomes
... 11.3% over the analysis period 2024-2030. Other Disease Indications, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$377.0 Million by the end of the analysis period. ... Read More
-
Exterior Insulation and Finish Systems (EIFS)
... reach US$173.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Polymer-based EIFS, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach ... Read More
-
Food Grade Glycerin
... at a CAGR of 5.7% over the analysis period 2024-2030. Personal Care Application, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$937.1 Million by the end ... Read More
-
Gaucher Disease Treatment
... at a CAGR of 3.8% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
Genome Editing / Genome Engineering
... Billion by 2030, growing at a CAGR of 19.8% over the analysis period 2024-2030. CRISPR Technology, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$18.7 Billion ... Read More
-
Glucose, Dextrose, and Maltodextrin
... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Glucose, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$32.3 Billion by the end ... Read More
-
Glycerol
... 3.6% over the analysis period 2024-2030. Personal Care & Cosmetics End-Use, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.4 Billion by the end of the ... Read More
-
Glycomics / Glycobiology
... at a CAGR of 16.9% over the analysis period 2024-2030. Glycomics / Glycobiology Enzymes, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.9 Billion by the ... Read More
-
GMO Testing
... CAGR of 7.0% over the analysis period 2024-2030. Stacked Trait Testing, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Healthcare Biometrics
... CAGR of 18.5% over the analysis period 2024-2030. Multi-Factor Authentication Technology, one of the segments analyzed in the report, is expected to record a 25.6% CAGR and reach US$4.6 Billion by the end of the ... Read More
-
Heart Pump Devices
... at a CAGR of 17.4% over the analysis period 2024-2030. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$5.1 Billion by the ... Read More
-
Worldwide Biotech February 2025
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More
-
Gel Electrophoresis
... CAGR of 5.3% over the analysis period 2024-2030. Laboratory Research End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the ... Read More
Research Assistance
